Managers / Q1 2020 · view latest →
Noked Israel Ltd
CIK 0001767750 · 22 HAGEFEN ST, RAMAT HASHARON, L3, 4725422 · 972-73-780-3400
Summary
Noked Israel Ltd reported $56M in U.S.-listed holdings across 14 positions for Q1 2020.
The portfolio is heavily concentrated: TEVA alone accounts for 41.6% of reported value.
Compared with Q4 2019, the fund opened 6 new positions and exited 50.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ADR · 44.3% · $25M
- Common Stock · 40.1% · $22M
- Other · 15.6% · $9M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| TEVATEVA PHARMACEUTICAL INDS LTD | NEW | +2.60M | 2.60M | +$23M | $23M |
| NTRNUTRIEN LTD | NEW | +90.0K | 90.0K | +$3M | $3M |
| ORAORMAT TECHNOLOGIES INC | NEW | +30.0K | 30.0K | +$2M | $2M |
| BABAALIBABA GROUP HLDG LTD | NEW | +6.9K | 6.9K | +$1M | $1M |
| SAPIENS INTL CORP N V | NEW | +24.6K | 24.6K | +$469,000 | $469,000 |
| ITMRITAMAR MED LTD | NEW | +14.8K | 14.8K | +$174,000 | $174,000 |
| RADA ELECTR INDS LTD | ADDED | +1.20M | 1.45M | +$4M | $5M |
| AMZNAMAZON COM INC | ADDED | +380 | 670 | +$770,000 | $1M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2020
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | TEVATEVA PHARMACEUTICAL INDS LTDhistory → | SPONSORED ADS | 41.62% | $23M | 2.60M |
| 2 | SEDGSOLAREDGE TECHNOLOGIES INChistory → | COM | 17.77% | $10M | 121.5K |
| 3 | MSFTMICROSOFT CORPhistory → | COM | 10.89% | $6M | 38.7K |
| 4 | RADA ELECTR INDS LTD | COM PAR NEW | 9.08% | $5M | 1.45M |
| 5 | NTRNUTRIEN LTDhistory → | COM | 5.46% | $3M | 90.0K |
| 6 | ORAORMAT TECHNOLOGIES INChistory → | COM | 3.63% | $2M | 30.0K |
| 7 | CIM COML TR CORP | COM NEW | 2.40% | $1M | 121.4K |
| 8 | BABAALIBABA GROUP HLDG LTDhistory → | SPONSORED ADS | 2.40% | $1M | 6.9K |
| 9 | G WILLI FOOD INTL LTD | ORD | 2.35% | $1M | 117.3K |
| 10 | AMZNAMAZON COM INChistory → | COM | 2.33% | $1M | 670 |
| 11 | SAPIENS INTL CORP N V | SHS | 0.84% | $469,000 | 24.6K |
| 12 | ELLOMAY CAPITAL LTD | SHS | 0.51% | $284,000 | 20.0K |
| 13 | XTL BIOPHARMACEUTICALS LTD | SPONSORED ADR NE | 0.42% | $234,000 | 198.9K |
| 14 | ITMRITAMAR MED LTD | SPONSORED ADS | 0.31% | $174,000 | 14.8K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $677M | 13 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $624M | 14 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $639M | 14 | Nov 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $542M | 12 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $436M | 15 | May 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $508M | 16 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $458M | 18 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $362M | 15 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $372M | 22 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $379M | 31 | Feb 15, 2024 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2023 | $330M | 28 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $292M | 35 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $230M | 22 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $262M | 27 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $411M | 50 | Dec 27, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q2 2022 | $435M | 48 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $329M | 42 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $407M | 45 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $425M | 46 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $401M | 35 | Aug 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $307M | 33 | May 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $243M | 27 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $151M | 22 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $140M | 16 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $56M | 14 | May 27, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2019 | $89M | 58 | Feb 18, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $95M | 38 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $82M | 81 | Aug 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $96M | 72 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.